Theranexus (XPAR:ALTHX) Purchase Of Property, Plant, Equipment : €-0.03 Mil (TTM As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Theranexus Purchase Of Property, Plant, Equipment?

Theranexus's purchase of property, plant, equipment for the six months ended in Dec. 2023 was €-0.03 Mil. It means Theranexus spent €0.03 Mil on purchasing property, plant, equipment. Theranexus's purchase of property, plant, equipment for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.03Mil.

Compared with last quarter (€-0.00 Mil in Jun. 2023 ), Theranexus spent more money on purchasing property, plant, equipment in Dec. 2023 (€-0.03 Mil).

Theranexus Purchase Of Property, Plant, Equipment Historical Data

The historical data trend for Theranexus's Purchase Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theranexus Purchase Of Property, Plant, Equipment Chart

Theranexus Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Purchase Of Property, Plant, Equipment

Get a 7-Day Free Trial

-0.98

-0.02

-0.04

Theranexus Semi-Annual Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Purchase Of Property, Plant, Equipment	Get a 7-Day Free Trial												-0.01	-0.04	-	-	-0.03

Theranexus Purchase Of Property, Plant, Equipment Calculation

The amount used to purchase PPE.

Purchase Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.03 Mil.

Theranexus Purchase Of Property, Plant, Equipment Related Terms

Thank you for viewing the detailed overview of Theranexus's Purchase Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.

Theranexus (XPAR:ALTHX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theranexus SA (XPAR:ALTHX) » Definitions » Purchase Of Property, Plant, Equipment

Comparable Companies

Traded in Other Exchanges

3VG:Germany

Address

60 avenue Rockefeller, Pepiniere Laennec, Lyon, FRA, 69008

Website

https://www.theranexus.com

Theranexus SA is a France based biopharmaceutical company. It is engaged in developing drug candidates to be used in the treatment of central nervous system (CNS) disorders. The company's therapeutics platform is based on simultaneously targeting neurons and glial cells by creating and developing innovative combinations of two distinct drugs: a CNS drug targeting neuronal activity; and a drug targeting glial cells. The drug candidates of the organization are THN102 to treat excessive daytime sleepiness in Parkinson's disease, THN201 for the treatment of neurocognitive disorders in Alzheimer's disease and THN101 for neuropathic pain.

Theranexus (XPAR:ALTHX) Headlines

No Headlines